Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SMS 201-995' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 557 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Trobonjaca, Z; Radosevic-Stasic, B; Crncevic, Z; Rukavina, D
      Modulatory effects of octreotide on anti-CD3 and dexamethasone-induced apoptosis of murine thymocytes

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Parkinson, C; Trainer, PJ
      The place of pegvisomant in the management of acromegaly

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    3. Orlandi, F; Caraci, P; Mussa, A; Saggiorato, E; Pancani, G; Angeli, A
      Treatment of medullary thyroid carcinoma: an update

      ENDOCRINE-RELATED CANCER
    4. Jiang, SK; Gazal, S; Gelerman, G; Ziv, O; Karpov, O; Litman, P; Bracha, M; Afargan, M; Gilon, C; Goodman, M
      A bioactive somatostatin analog-without a type II ' beta-turn: Synthesis and conformational analysis in solution

      JOURNAL OF PEPTIDE SCIENCE
    5. Falb, E; Salitra, Y; Yechezkel, T; Bracha, M; Litman, P; Olender, R; Rosenfeld, R; Senderowitz, H; Jiang, SK; Goodman, M
      A bicyclic and hsst2 selective somatostatin analogue: Design, synthesis, conformational analysis and binding

      BIOORGANIC & MEDICINAL CHEMISTRY
    6. Ho, W; Jung, BP; Zhang, GM; Eubanks, JH
      Somatostatin type 2 receptor expression in the rat hippocampus following cerebral ischemia

      NEUROREPORT
    7. Sabba, C; Buonamico, P; Vendemiale, G; Berardi, E; Antonica, G; Palmieri, V; Merkel, C; Palasciano, G
      Haemodynamic effects of propranolol, octreotide and their combination during fasting and post-prandial splanchnic hyperaemia in patients with cirrhosis

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    8. Hofland, LJ; Lamberts, SWJ
      Somatostatin receptor subtype expression in human tumors

      ANNALS OF ONCOLOGY
    9. Oomen, SPMA; Lichtenauer-Kaligis, EGR; Verplanke, N; Hofland, J; Lamberts, SWJ; Lowenberg, B; Touw, IP
      Somatostatin induces migration of acute myeloid leukemia cells via activation of somatostatin receptor subtype 2

      LEUKEMIA
    10. Abe, T; Ludecke, DK
      Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    11. Cascinu, S; Del Ferro, E; Ligi, M; Staccioli, MP; Giordani, P; Catalano, V; Agostinelli, R; Muretto, P; Catalano, G
      Inhibition of vascular endothelial growth factor by octreotide in colorectal cancer patients

      CANCER INVESTIGATION
    12. Ripamonti, C; Panzeri, C; Groff, L; Galeazzi, G; Boffi, R
      The role of somatostatin and octreotide in bowel obstruction: Pre-clinicaland clinical results

      TUMORI
    13. Fassnacht, M; Capeller, B; Arlt, W; Steck, T; Allolio, B
      Octreotide LAR (R) treatment throughout pregnancy in an acromegalic woman

      CLINICAL ENDOCRINOLOGY
    14. Ferone, D; Pivonello, R; Lastoria, S; Faggiano, A; de Caro, MLD; Cappabianca, P; Lombardi, G; Colao, A
      In vivo and in vitro effects of octreotide, quinagolide and cabergoline infour hyperprolactinaemic acromegalics: Correlation with somatostatin and dopamine D-2 receptor scintigraphy

      CLINICAL ENDOCRINOLOGY
    15. Gonzalez, D; Elizondo, BJ; Haslag, S; Buchanan, G; Burdick, JS; Guzzetta, PC; Hicks, BA; Andersen, JM
      Chronic subcutaneous octreotide decreases gastrointestinal blood loss in blue rubber-bleb nevus syndrome

      JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
    16. Pereira, SP; Hussaini, SH; Murphy, GM; Wass, JAH; Dowling, RH
      Octreotide increases the proportions of arachidonic acid-rich phospholipids in gall-bladder bile

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    17. Moschetta, A; Stolk, MFJ; Rehfeld, JF; Portincasa, P; Slee, PHTJ; Koppeschaar, HPF; Van Erpecum, KJ; Vanberge-Henegouwen, GP
      Severe impairment of postprandial cholecystokinin release and gall-bladderemptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    18. Bruttomesso, D; Fongher, C; Silvestri, B; Barberio, S; Marescotti, MC; Iori, E; Valerio, A; Crazzolara, D; Pianta, A; Tiengo, A; Del Prato, S
      Combination of continuous subcutaneous infusion of insulin and octreotide in Type 1 diabetic patients

      DIABETES RESEARCH AND CLINICAL PRACTICE
    19. Di Mauro, M; Papalia, G; Le Moli, R; Nativo, B; Nicoletti, F; Lunetta, M
      Effect of octreotide on insulin requirement, hepatic glucose production, growth hormone, glucagon and c-peptide levels in type 2 diabetic patients with chronic renal failure or normal renal function

      DIABETES RESEARCH AND CLINICAL PRACTICE
    20. Veal, N; Auduberteau, H; Lemarie, C; Oberti, F; Cales, P
      Effects of octreotide on intestinal transit and bacterial translocation inconscious rats with portal hypertension and liver fibrosis

      DIGESTIVE DISEASES AND SCIENCES
    21. Orsenigo, R; Gatti, S; Latham, L; Trezza, P; Marelli, O
      FK506 and SMS 201-995: Effect on heterotopic heart transplantation in rats

      TRANSPLANTATION PROCEEDINGS
    22. Brentjens, R; Saltz, L
      Islet cell tumors of the pancreas - The medical oncologist's perspective

      SURGICAL CLINICS OF NORTH AMERICA
    23. Raderer, M; Kurtaran, A; Scheithauer, W; Fiebiger, W; Weinlaender, G; Oberhuber, G
      Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid

      ONCOLOGY
    24. Danila, DC; Haidar, JNS; Zhang, X; Katznelson, L; Culler, MD; Klibanski, A
      Somatostatin receptor-specific analogs: Effects on cell proliferation and growth hormone secretion in human somatotroph tumors

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    25. Caron, P; Arlot, S; Bauters, C; Chanson, P; Kuhn, JM; Pugeat, M; Marechaud, R; Teutsch, C; Vidal, E; Sassano, P
      Efficacy of the long-acting octreotide formulation (Octreotide-Lar) in patients with thyrotropin-secreting pituitary adenomas

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    26. Losa, M; Ciccarelli, E; Mortini, P; Barzaghi, R; Gaia, D; Faccani, G; Papotti, M; Mangili, F; Terreni, MR; Camanni, F; Giovanelli, M
      Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    27. Hesse, U; Ysebaert, D; de Hemptinne, B
      Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: clinical data

      GUT
    28. Nishida, H; Giostra, E; Spahr, L; Mentha, G; Mitamura, K; Hadengue, A
      Validation of color Doppler EUS for azygos blood flow measurement in patients with cirrhosis: application to the acute hemodynamic effects of somatostatin, octreotide, or placebo

      GASTROINTESTINAL ENDOSCOPY
    29. Veysey, MJ; Thomas, LA; Mallet, AI; Jenkins, PJ; Besser, GM; Murphy, GM; Dowling, RH
      Colonic transit influences deoxycholic acid kinetics

      GASTROENTEROLOGY
    30. Escorsell, A; Bandi, JC; Andreu, V; Moitinho, E; Garcia-Pagan, JC; Bosch, J; Rodes, J
      Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension

      GASTROENTEROLOGY
    31. Scarpignato, C; Pelosini, I
      Somatostatin analogs for cancer treatment and diagnosis: An overview

      CHEMOTHERAPY
    32. Dean, A
      The palliative effects of octreotide in cancer patients

      CHEMOTHERAPY
    33. Vainas, IG
      Octreotide in the management of hormone-refractory prostate cancer

      CHEMOTHERAPY
    34. Cascinu, S; Catalano, V; Giordani, P; Baldelli, AM; Agostinelli, R; Catalano, G
      Gastrointestinal cancer refractory to chemotherapy: A role for octreotide?

      CHEMOTHERAPY
    35. Rosenberg, L
      Pancreatic cancer: Does octreotide offer any promise?

      CHEMOTHERAPY
    36. Li-Ling, J; Irving, M
      Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials

      BRITISH JOURNAL OF SURGERY
    37. Nehra, V; Camilleri, M; Burton, D; Oenning, L; Kelly, DG
      An open trial of octreotide long-acting release in the management of shortbowel syndrome

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    38. Ferone, D; Colao, A; van de Lely, AJ; Lamberts, SWJ
      Pharmacotherapy or surgery as primary treatment for acromegaly?

      DRUGS & AGING
    39. Oberg, K
      State of the art and future prospects in the management of neuroendocrine tumors

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    40. Usenmez, T; Yildiz, O; Oktenli, C; Ozgurtas, T; Kutlu, M
      Octreotide administration in diabetic rats: effects on renal function and morphology

      JOURNAL OF DIABETES AND ITS COMPLICATIONS
    41. Heppeler, A; Froidevaux, S; Eberle, AN; Maecke, HR
      Receptor targeting for tumor localisation and therapy with radiopeptides

      CURRENT MEDICINAL CHEMISTRY
    42. Stroh, T; Jackson, AC; Farra, CD; Schonbrunn, A; Vincent, JP; Beaudet, A
      Receptor-mediated internalization somatostatin in rat cortical and hippocampal neurons

      SYNAPSE
    43. Verhelst, JA; Pedroncelli, AM; Abs, R; Montini, M; Vandeweghe, M; Albani, G; Maiter, D; Pagani, MD; Legros, JJ; Gianola, D; Bex, M; Poppe, K; Mockel, J; Pagani, G
      Slow-release lanreotide in the treatment of acromegaly: a study in 66 patients

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    44. Caron, P; Tabarin, A; Cogne, M; Chanson, P; Jaquet, P
      Variable growth hormone profiles following withdrawal of long-term 30 mg slow-release lanreotide treatment in acromegalic patients: clinical implications

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    45. Wasko, R; Ruchala, M; Sawicka, J; Kotwicka, M; Liebert, W; Sowinski, J
      Short-term pre-surgical treatment with somatostatin analogues, octreotide and lanreotide, in acromegaly

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    46. Alvarez, C; McFadden, DW; Reber, HA
      Complicated enterocutaneous fistulas: Failure of octreotide to improve healing

      WORLD JOURNAL OF SURGERY
    47. Zhou, HH; Chen, TL; Marino, M; Lau, H; Miller, T; Kalafsky, G; McLeod, JF
      Population PK and PK/PD modelling of microencapsulated octreotide acetate in healthy subjects

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    48. Koriyama, N; Kakei, M; Yaekura, K; Okui, H; Yamashita, T; Nishimura, H; Matsushita, S; Tei, C
      Control of catecholamine release and blood pressure with octreotide in a patient with pheochromocytoma: A case report with in vitro studies

      HORMONE RESEARCH
    49. Zellos, A; Schwarz, KB
      Efficacy of octreotide in children with chronic gastrointestinal bleeding

      JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
    50. Dowling, RH
      Review: pathogenesis of gallstones

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    51. Zalatnai, A; Szegedi, Z; Bocsi, J
      Flow cytometric evidence of apoptosis in human pancreatic cancer xenografts treated with sandostatin (octreotide)

      ANTICANCER RESEARCH
    52. Makhdoom, ZA; Komar, MJ; Still, CD
      Nutrition and enterocutaneous fistulas

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    53. Patel, YC; Ezzat, S; Chik, CL; Rorstad, OP; Serri, O; Ur, E; Wilkins, GE
      Guidelines for the diagnosis and treatment of acromegaly: a Canadian perspective

      CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE
    54. Mattern, RH; Moore, SB; Tran, TA; Rueter, JK; Goodman, M
      Synthesis, biological activities and conformational studies of somatostatin analogs

      TETRAHEDRON
    55. Thanou, M; Verhoef, JC; Marbach, P; Junginger, HE
      Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo

      JOURNAL OF PHARMACEUTICAL SCIENCES
    56. Greenberg, R; Haddad, R; Kashtan, H; Kaplan, O
      The effects of somatostatin and octreotide on experimental and human acutepancreatitis

      JOURNAL OF LABORATORY AND CLINICAL MEDICINE
    57. Herman-Bonert, VS; Zib, K; Scarlett, JA; Melmed, S
      Growth hormone receptor antagonist therapy in acromegalic patients resistant to somatostatin analogs

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    58. Kuhn, JM; Arlot, S; Lefebvre, H; Caron, P; Cortet-Rudelli, C; Archambaud, F; Chanson, P; Tabarin, A; Goth, MI; Blumberg, J; Catus, F; Ispas, S; Beck-Peccoz, P
      Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    59. Pop-Busui, R; Chey, W; Stevens, MJ
      Severe hypertension induced by the long-acting somatostatin analogue sandostatin LAR in a patient with diabetic autonomic neuropathy

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    60. Vitale, G; Tagliaferri, P; Caraglia, M; Rampone, E; Ciccarelli, A; Bianco, AR; Abbruzzese, A; Lupoli, G
      Slow release lanreotide in combination with interferon-alpha 2b in the treatment of symptomatic advanced medullary thyroid carcinoma

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    61. Rosenberg, L
      Pancreatic cancer - A review of emerging therapies

      DRUGS
    62. Mattern, RH; Zhang, L; Rueter, JK; Goodman, M
      Conformational analyses of sandostatin analogs containing stereochemical changes in positions 6 or 8

      BIOPOLYMERS
    63. Lawnicka, H; Stepien, H; Wyczolkowska, J; Kolago, B; Kunert-Radek, J; Komorowski, J
      Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line (HECa10) culture

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    64. Li, JKU; Chow, CC; Yeung, VTF; Mak, TWL; Ko, GTC; Swaminathan, R; Chan, JCN; Cockram, CS
      Treatment of Chinese acromegaly with a combination of bromocriptine and octreotide

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE
    65. Gervaise, N; Combe, H; Lecomte, P
      Acromegaly in 2000

      ANNALES D ENDOCRINOLOGIE
    66. Ducreux, M; Ruszniewski, P; Chayvialle, JA; Blumberg, J; Cloarec, D; Michel, H; Raymond, JM; Dupas, JL; Gouerou, H; Jian, R; Genestin, E; Hammel, P; Rougier, P
      The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    67. Alatas, E; Alatas, O; Colak, O
      Octreotide inhibits myeloperoxidase activity in rat uterus

      ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
    68. Iuchi, T; Saeki, N; Osato, K; Yamaura, A
      Proliferation, vascular endothelial growth factor expression and cavernoussinus invasion in growth hormone secreting pituitary adenomas

      ACTA NEUROCHIRURGICA
    69. Stewart, PM; James, RA
      The future of somatostatin analogue therapy

      BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
    70. Janson, ET; Oberg, K
      Somatostatin receptor ligands and their use in the treatment of endocrine disorders

      CURRENT PHARMACEUTICAL DESIGN
    71. Angeletti, S; Corleto, VD; Schillaci, O; Moretti, A; Panzuto, F; Annibale, B; Delle Fave, G
      Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumours

      ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    72. Yun, YS; Lee, HC; Park, CS; Chang, KH; Cho, CH; Song, YD; Lim, SK; Kim, KR; Huh, KB
      Effects of long-acting somatostatin analogue (Sandostatin) on manifest diabetic ketoacidosis

      JOURNAL OF DIABETES AND ITS COMPLICATIONS
    73. Hsu, DW; Hedley-Whyte, ET
      Clinical interpretation of special pathologic procedures applied to pituitary adenoma biopsies: Immunocytochemistry, electron microscopy, and cell proliferative studies

      ENDOCRINOLOGIST
    74. Eriksson, B; Oberg, K
      Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: Future outlook

      ANNALS OF ONCOLOGY
    75. Shimatsu, A; Murabe, H; Kamoi, K; Suzuki, Y; Nakao, K
      Treatment of thyrotropin-secreting pituitary adenomas with octreotide

      ENDOCRINE JOURNAL
    76. Lin, JD; Lee, ST; Weng, HF
      An open, phase III study of lanreotide (Somatuline PR (R)) in the treatment of acromegaly

      ENDOCRINE JOURNAL
    77. Yamakita, N; Komaki, T; Murai, T; Kawamura, S
      Reduction of plasma gonadotropin levels and pituitary tumor size by treatment with bromocriptine in a patient with gonadotropinoma

      INTERNAL MEDICINE
    78. Newman, CB
      Medical therapy for acromegaly

      ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
    79. Sharma, K; Patel, YC; Srikant, CB
      C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G(1) cell cycle arrest

      MOLECULAR ENDOCRINOLOGY
    80. Skoric, T; Korsic, M; Zarkovic, K; Plavsic, V; Besenski, N; Breskovac, L; Giljevic, Z; Paladino, J
      Clinical and morphological features of undifferentiated monomorphous GH/TSH-secreting pituitary adenoma

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    81. Plockinger, U; Holst, JJ; Messerschmidt, D; Hopfenmuller, W; Quabbe, HJ
      Octreotide suppresses the incretin glucagon-like peptide (7-36) amide in patients with acromegaly or clinically nonfunctioning pituitary tumors and in healthy subjects

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    82. Losa, M; Mortini, P; Giovanelli, M
      Is presurgical treatment with somatostatin analogs necessary in acromegalic patients?

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    83. Colao, A; Marzullo, P; Ferone, D; Marino, V; Pivonello, R; Di Somma, C; Di Sarno, A; Giaccio, A; Lombardi, G
      Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    84. Smedh, U; Kaplan, JM; Bjorkstrand, E; Uvnas-Moberg, K
      Dual effects of somatostatin analog octreotide on gastric emptying during and after intragastric fill

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    85. Criado, JR; Li, HT; Jiang, XH; Spina, M; Huitron-Resendiz, S; Liapakis, G; Calbet, M; Siehler, S; Henriksen, SJ; Koob, G; Hoyer, D; Sutcliffe, JG; Goodman, M; de Lecea, L
      Structural and compositional determinants of cortistatin activity

      JOURNAL OF NEUROSCIENCE RESEARCH
    86. Ritz, MA; Drewe, J; Ziel, A; Hildebrand, P; Schneider, P; Lahlou, N; Beglinger, C
      The effects of vapreotide, a somatostatin analogue, on gastric acidity, gallbladder emptying and hormone release after 1 week of continuous subcutaneous infusion in normal subjects

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    87. El-Salhy, M; Sandstrom, O
      How age changes the content of neuroendocrine peptides in the murine gastrointestinal tract

      GERONTOLOGY
    88. Vecht, J; Lamers, CBHW; Masclee, AAM
      Long-term results of octreotide-therapy in severe dumping syndrome

      CLINICAL ENDOCRINOLOGY
    89. El Ghamrawy, C; Rabourdin-Combe, C; Krantic, S
      sst5 somatostatin receptor mRNA induction by mitogenic activation of humanT-lymphocytes

      PEPTIDES
    90. Chao, TC; Chao, HH; Lin, JD; Chen, MF
      Somatostatin and octreotide modulate the function of Kupffer cells in liver cirrhosis

      REGULATORY PEPTIDES
    91. Duet, M; Ajzenberg, C; Benelhadj, S; Lajeunie, E; Lormeau, B; Guillausseau, PJ; Rohmer, V; Vilain, D; Mundler, O; Warnet, A
      Somatostatin receptor scintigraphy in pituitary adenomas: A somatostatin receptor density index can predict hormonal and tumoral efficacy of octreotide in vivo

      JOURNAL OF NUCLEAR MEDICINE
    92. Moser, AJ; Giurgiu, DIN; Morgenstern, KE; Abedin, ZR; Roslyn, JJ; Abedin, MZ
      Octreotide stimulates Ca++ secretion by the gallbladder: A risk factor forgallstones

      SURGERY
    93. Sanchez, R; Boix, E; Navarro, MD; Pico, A
      Pregnancy in an acromegalic patient treated with lanreotide and bromocriptine

      MEDICINA CLINICA
    94. Van den Bruel, A; Fevery, J; Van Dorpe, J; Hofland, L; Bouillon, R
      Hormonal and volumetric long term control of a growth hormone-releasing hormone-producing carcinoid tumor

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    95. de Menis, E; Billeci, D; Marton, E
      Uneventful pregnancy in an acromegalic patient treated with slow-release lanreotide: A case report

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    96. Thangaraju, M; Sharma, K; Leber, B; Andrews, DW; Shen, SH; Srikant, CB
      Regulation of acidification and apoptosis by SHP-1 and Bcl-2

      JOURNAL OF BIOLOGICAL CHEMISTRY
    97. Sellers, LA
      Prolonged activation of extracellular signal-regulated kinase by a proteinkinase C-dependent and N17Ras-insensitive mechanism mediates the proliferative response of G(i/o)-coupled somatostatin sst(4) receptors

      JOURNAL OF BIOLOGICAL CHEMISTRY
    98. Uhl, W; Buchler, MW; Malfertheiner, P; Beger, HG; Adler, G; Gaus, W
      A randomised, double blind, multicentre trial of octreotide in moderate tosevere acute pancreatitis

      GUT
    99. Veysey, MJ; Thomas, LA; Mallet, AI; Jenkins, PJ; Besser, GM; Wass, JAH; Murphy, GM; Dowling, RH
      Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones

      GUT
    100. Bufalari, A; Ferri, M; Sidoni, A; Alberti, P; Giustozzi, G; Moggi, L
      Pancreatic regeneration after subtotal distal resection in rats - Effects of bombesin and octreotide by the in vivo bromodeoxyuridine uptake technique

      EUROPEAN SURGICAL RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 23:58:33